Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 5.35598938 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.04474187 |
3 | glycosphingolipid catabolic process (GO:0046479) | 4.96447572 |
4 | locomotory exploration behavior (GO:0035641) | 4.73018779 |
5 | glycolipid catabolic process (GO:0019377) | 4.52220369 |
6 | synaptic vesicle exocytosis (GO:0016079) | 4.49938892 |
7 | barbed-end actin filament capping (GO:0051016) | 4.46714982 |
8 | oligosaccharide catabolic process (GO:0009313) | 4.33873259 |
9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.27845690 |
10 | cellular potassium ion homeostasis (GO:0030007) | 4.26843658 |
11 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.25193575 |
12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.24266041 |
13 | sodium ion export (GO:0071436) | 4.23255766 |
14 | glutamate secretion (GO:0014047) | 4.19135664 |
15 | amino sugar catabolic process (GO:0046348) | 4.16534629 |
16 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.14347493 |
17 | protein localization to endosome (GO:0036010) | 4.13760070 |
18 | regulation of synapse structural plasticity (GO:0051823) | 4.10998345 |
19 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.93968731 |
20 | adhesion of symbiont to host cell (GO:0044650) | 3.90591248 |
21 | virion attachment to host cell (GO:0019062) | 3.90591248 |
22 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.90520245 |
23 | adhesion of symbiont to host (GO:0044406) | 3.90244906 |
24 | vocalization behavior (GO:0071625) | 3.79265745 |
25 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.77255181 |
26 | neuronal action potential propagation (GO:0019227) | 3.76833335 |
27 | ceramide catabolic process (GO:0046514) | 3.76654862 |
28 | regulation of mononuclear cell migration (GO:0071675) | 3.75030882 |
29 | regulation of synaptic vesicle transport (GO:1902803) | 3.74746363 |
30 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.64682859 |
31 | response to thyroid hormone (GO:0097066) | 3.64124471 |
32 | regulation of cholesterol storage (GO:0010885) | 3.61234265 |
33 | proline transport (GO:0015824) | 3.59775571 |
34 | membrane lipid catabolic process (GO:0046466) | 3.58581652 |
35 | L-amino acid import (GO:0043092) | 3.57197104 |
36 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.57083917 |
37 | neurotransmitter secretion (GO:0007269) | 3.56686523 |
38 | sphingolipid catabolic process (GO:0030149) | 3.49196758 |
39 | regulation of early endosome to late endosome transport (GO:2000641) | 3.49107161 |
40 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.48524771 |
41 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.46698963 |
42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.43428407 |
43 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.40444736 |
44 | exploration behavior (GO:0035640) | 3.39792366 |
45 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.38529509 |
46 | protein retention in ER lumen (GO:0006621) | 3.37916733 |
47 | regulation of ARF protein signal transduction (GO:0032012) | 3.36432690 |
48 | layer formation in cerebral cortex (GO:0021819) | 3.31314190 |
49 | apoptotic cell clearance (GO:0043277) | 3.25306087 |
50 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.22215631 |
51 | activation of protein kinase A activity (GO:0034199) | 3.21763623 |
52 | N-acetylneuraminate metabolic process (GO:0006054) | 3.21350357 |
53 | protein localization to synapse (GO:0035418) | 3.19046644 |
54 | neuromuscular process controlling balance (GO:0050885) | 3.18232096 |
55 | gamma-aminobutyric acid transport (GO:0015812) | 3.15520273 |
56 | Golgi transport vesicle coating (GO:0048200) | 3.15110708 |
57 | COPI coating of Golgi vesicle (GO:0048205) | 3.15110708 |
58 | long-term memory (GO:0007616) | 3.15070158 |
59 | glycine transport (GO:0015816) | 3.14861485 |
60 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.14807002 |
61 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.12582766 |
62 | potassium ion homeostasis (GO:0055075) | 3.12015506 |
63 | amyloid precursor protein catabolic process (GO:0042987) | 3.11930685 |
64 | response to peptidoglycan (GO:0032494) | 3.11895475 |
65 | neuromuscular process controlling posture (GO:0050884) | 3.10783027 |
66 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.09752732 |
67 | regulation of macrophage chemotaxis (GO:0010758) | 3.07648855 |
68 | response to acidic pH (GO:0010447) | 3.06783830 |
69 | glutamate receptor signaling pathway (GO:0007215) | 3.06652946 |
70 | low-density lipoprotein particle clearance (GO:0034383) | 3.06548515 |
71 | potassium ion import (GO:0010107) | 3.05073028 |
72 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.05062441 |
73 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.01733667 |
74 | pinocytosis (GO:0006907) | 2.99815095 |
75 | synaptic transmission, glutamatergic (GO:0035249) | 2.98839837 |
76 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.97603709 |
77 | amino acid import (GO:0043090) | 2.96320444 |
78 | negative regulation of interleukin-12 production (GO:0032695) | 2.95996321 |
79 | regulation of synaptic plasticity (GO:0048167) | 2.94723007 |
80 | alanine transport (GO:0032328) | 2.93987237 |
81 | cellular sodium ion homeostasis (GO:0006883) | 2.93628590 |
82 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.93434931 |
83 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91802117 |
84 | neurotransmitter transport (GO:0006836) | 2.91639482 |
85 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.90284409 |
86 | ganglioside metabolic process (GO:0001573) | 2.89180934 |
87 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.85442786 |
88 | modulation by symbiont of host cellular process (GO:0044068) | 2.84742788 |
89 | vesicle transport along microtubule (GO:0047496) | 2.83922967 |
90 | transferrin transport (GO:0033572) | 2.83533067 |
91 | neuron-neuron synaptic transmission (GO:0007270) | 2.82691755 |
92 | dendritic spine morphogenesis (GO:0060997) | 2.82430348 |
93 | long-term synaptic potentiation (GO:0060291) | 2.80951303 |
94 | cell communication by electrical coupling (GO:0010644) | 2.80913852 |
95 | synaptic vesicle endocytosis (GO:0048488) | 2.80356156 |
96 | stress fiber assembly (GO:0043149) | 2.79975799 |
97 | neuron cell-cell adhesion (GO:0007158) | 2.79062457 |
98 | positive regulation of leukocyte degranulation (GO:0043302) | 2.78192130 |
99 | nerve growth factor signaling pathway (GO:0038180) | 2.78122321 |
100 | regulation of neurotransmitter levels (GO:0001505) | 2.77682457 |
101 | regulation of postsynaptic membrane potential (GO:0060078) | 2.76772792 |
102 | regulation of cholesterol esterification (GO:0010872) | 2.75864380 |
103 | positive regulation of membrane potential (GO:0045838) | 2.74198688 |
104 | NIK/NF-kappaB signaling (GO:0038061) | 2.73901597 |
105 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.73546285 |
106 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.73488596 |
107 | glial cell migration (GO:0008347) | 2.71406723 |
108 | microglial cell activation (GO:0001774) | 2.71125478 |
109 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.69036368 |
110 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.67452130 |
111 | mating behavior (GO:0007617) | 2.67085464 |
112 | regulation of superoxide anion generation (GO:0032928) | 2.66866480 |
113 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.66674416 |
114 | cyclooxygenase pathway (GO:0019371) | 2.65647476 |
115 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.65151355 |
116 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.64651434 |
117 | regulation of beta-amyloid formation (GO:1902003) | 2.64305316 |
118 | cerebellar Purkinje cell layer development (GO:0021680) | 2.62977125 |
119 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.62899683 |
120 | regulation of neurotransmitter secretion (GO:0046928) | 2.62580965 |
121 | adenosine receptor signaling pathway (GO:0001973) | 2.62560716 |
122 | cellular response to arsenic-containing substance (GO:0071243) | 2.61265028 |
123 | prepulse inhibition (GO:0060134) | 2.61017105 |
124 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.60519855 |
125 | hyaluronan catabolic process (GO:0030214) | 2.60003765 |
126 | cell-cell junction maintenance (GO:0045217) | 2.59595548 |
127 | mannose metabolic process (GO:0006013) | 2.59593128 |
128 | regulation of podosome assembly (GO:0071801) | 2.58877393 |
129 | positive regulation of cholesterol efflux (GO:0010875) | 2.57976180 |
130 | dendrite morphogenesis (GO:0048813) | 2.57267425 |
131 | glucose 6-phosphate metabolic process (GO:0051156) | 2.57023321 |
132 | transmission of nerve impulse (GO:0019226) | 2.54792127 |
133 | clathrin coat assembly (GO:0048268) | 2.54449891 |
134 | activation of MAPKKK activity (GO:0000185) | 2.53751293 |
135 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.52629831 |
136 | regulation of extracellular matrix disassembly (GO:0010715) | 2.52351773 |
137 | macrophage activation involved in immune response (GO:0002281) | 2.52221419 |
138 | regulation of ARF GTPase activity (GO:0032312) | 2.51576806 |
139 | angiotensin maturation (GO:0002003) | 2.51427807 |
140 | phagosome maturation (GO:0090382) | 2.50559050 |
141 | membrane depolarization (GO:0051899) | 2.50553571 |
142 | trivalent inorganic cation transport (GO:0072512) | 2.50539740 |
143 | ferric iron transport (GO:0015682) | 2.50539740 |
144 | positive regulation of synaptic transmission (GO:0050806) | 2.50101558 |
145 | T-helper 1 type immune response (GO:0042088) | 2.50101174 |
146 | membrane depolarization during action potential (GO:0086010) | 2.49766620 |
147 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.49556580 |
148 | positive regulation of extracellular matrix organization (GO:1903055) | 2.49209644 |
149 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.49190609 |
150 | cellular copper ion homeostasis (GO:0006878) | 2.48738425 |
151 | myeloid dendritic cell differentiation (GO:0043011) | 2.48709504 |
152 | regulation of vesicle fusion (GO:0031338) | 2.48651623 |
153 | bone resorption (GO:0045453) | 2.47550180 |
154 | regulation of leukocyte degranulation (GO:0043300) | 2.47359062 |
155 | lysosome organization (GO:0007040) | 2.47304278 |
156 | lytic vacuole organization (GO:0080171) | 2.47304278 |
157 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.46335784 |
158 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.45028557 |
159 | regulation of neurotransmitter transport (GO:0051588) | 2.44952034 |
160 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.42316119 |
161 | regulation of synaptic transmission (GO:0050804) | 2.42153698 |
162 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.42126752 |
163 | decidualization (GO:0046697) | 2.42118402 |
164 | neuromuscular process (GO:0050905) | 2.41960955 |
165 | regulation of dendritic spine development (GO:0060998) | 2.41918380 |
166 | semaphorin-plexin signaling pathway (GO:0071526) | 2.40869085 |
167 | membrane repolarization (GO:0086009) | 2.40511435 |
168 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.40224428 |
169 | positive regulation of neurotransmitter transport (GO:0051590) | 2.39527085 |
170 | negative regulation of amino acid transport (GO:0051956) | 2.38634866 |
171 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.38328069 |
172 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.38261260 |
173 | membrane hyperpolarization (GO:0060081) | 2.37771941 |
174 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.36824392 |
175 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.36733343 |
176 | serine transport (GO:0032329) | 2.36001885 |
177 | plasma lipoprotein particle clearance (GO:0034381) | 2.35143849 |
178 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.34560197 |
179 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.33840734 |
180 | oligosaccharide metabolic process (GO:0009311) | 2.33671292 |
181 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.33544729 |
182 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.31999692 |
183 | receptor catabolic process (GO:0032801) | 2.31484517 |
184 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.29890724 |
185 | monocyte chemotaxis (GO:0002548) | 2.28656824 |
186 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.27872680 |
187 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.26890959 |
188 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.25355625 |
189 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.22934141 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.99048037 |
2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.61097560 |
3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.78931877 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.74924995 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.68613770 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.61635267 |
7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.57318588 |
8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.56308262 |
9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.44413027 |
10 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41997524 |
11 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.41685352 |
12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.36550170 |
13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.35938920 |
14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34122797 |
15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34100429 |
16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34100429 |
17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30561505 |
18 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.21754097 |
19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.21276284 |
20 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20678869 |
21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.20049209 |
22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.17876841 |
23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.17346875 |
24 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16687627 |
25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09269455 |
26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.08320783 |
27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.97672436 |
28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95444281 |
29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.95216494 |
30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.92201779 |
31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.87786102 |
32 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.87595314 |
33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85064967 |
34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.82202400 |
35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.77642128 |
36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.77221512 |
37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71322977 |
38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.66748828 |
39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64916592 |
40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.62544964 |
41 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.62106341 |
42 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59525890 |
43 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.56837445 |
44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56492847 |
45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55847895 |
46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55380096 |
47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54160747 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53996705 |
49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52446704 |
50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51009678 |
51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48970986 |
52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.48448558 |
53 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.46502620 |
54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45892347 |
55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.42912404 |
56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42262979 |
57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42128512 |
58 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.41006766 |
59 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39887662 |
60 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38088445 |
61 | P68_20966046_ChIP-Seq_HELA_Human | 1.38053353 |
62 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37516319 |
63 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37416139 |
64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37035185 |
65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36849938 |
66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33806012 |
67 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32197108 |
68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32156464 |
69 | MYC_22102868_ChIP-Seq_BL_Human | 1.31306702 |
70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29546857 |
71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29241362 |
72 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28813352 |
73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28333885 |
74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28220202 |
75 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27232499 |
76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26425184 |
77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25453598 |
78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24349455 |
79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24085807 |
80 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21880443 |
81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20548016 |
82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19573432 |
83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19406485 |
84 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18980216 |
85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17411075 |
86 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17080425 |
87 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17072043 |
88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16648499 |
89 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16617549 |
90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.16249161 |
91 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15689985 |
92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14539826 |
93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14247807 |
94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13185237 |
95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12945177 |
96 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.12841466 |
97 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.12677512 |
98 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12578000 |
99 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11929971 |
100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11334169 |
101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11095653 |
102 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10216128 |
103 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.10172851 |
104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10162914 |
105 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09937875 |
106 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09428990 |
107 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09289963 |
108 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09254889 |
109 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08345954 |
110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07627913 |
111 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06255130 |
112 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06081574 |
113 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.05940217 |
114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.05802076 |
115 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05702952 |
116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05505265 |
117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05301999 |
118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05290929 |
119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04679965 |
120 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04582984 |
121 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04154675 |
122 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04132421 |
123 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03520263 |
124 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02494264 |
125 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02167917 |
126 | ATF3_27146783_Chip-Seq_COLON_Human | 1.01783896 |
127 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.01455739 |
128 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01036693 |
129 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01002064 |
130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00188823 |
131 | AR_19668381_ChIP-Seq_PC3_Human | 1.00109993 |
132 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.99284650 |
133 | AR_25329375_ChIP-Seq_VCAP_Human | 0.99100697 |
134 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99084502 |
135 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.98974395 |
136 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98429031 |
137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98388619 |
138 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98328801 |
139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.96802522 |
140 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96518530 |
141 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.94749233 |
142 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94288526 |
143 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92853955 |
144 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92730898 |
145 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91864785 |
146 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91398127 |
147 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.90695046 |
148 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90245610 |
149 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.88809426 |
150 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86790617 |
151 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85574781 |
152 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84403485 |
153 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84258671 |
154 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83855035 |
155 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83253649 |
156 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83227879 |
157 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82748976 |
158 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82054361 |
159 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81545902 |
160 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81366419 |
161 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.81317387 |
162 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.80108290 |
163 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79493360 |
164 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.78893863 |
165 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.78863882 |
166 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.77700104 |
167 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.77078393 |
168 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76962975 |
169 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76962975 |
170 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76523256 |
171 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.76309337 |
172 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.76253588 |
173 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76244753 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.22184201 |
2 | MP0003635_abnormal_synaptic_transmissio | 3.65052895 |
3 | MP0003880_abnormal_central_pattern | 3.59335511 |
4 | MP0004270_analgesia | 3.17396672 |
5 | MP0002139_abnormal_hepatobiliary_system | 3.14460392 |
6 | MP0002064_seizures | 3.05411688 |
7 | MP0005058_abnormal_lysosome_morphology | 3.00950965 |
8 | MP0009745_abnormal_behavioral_response | 2.81789063 |
9 | MP0002063_abnormal_learning/memory/cond | 2.79126961 |
10 | MP0003172_abnormal_lysosome_physiology | 2.74726533 |
11 | MP0009046_muscle_twitch | 2.62212012 |
12 | MP0001968_abnormal_touch/_nociception | 2.60734475 |
13 | MP0004858_abnormal_nervous_system | 2.50128942 |
14 | MP0003690_abnormal_glial_cell | 2.50082001 |
15 | MP0002822_catalepsy | 2.45557529 |
16 | MP0003329_amyloid_beta_deposits | 2.37334193 |
17 | MP0002572_abnormal_emotion/affect_behav | 2.29264409 |
18 | MP0003075_altered_response_to | 2.23099863 |
19 | MP0002736_abnormal_nociception_after | 2.19511948 |
20 | MP0002909_abnormal_adrenal_gland | 2.16249228 |
21 | MP0003436_decreased_susceptibility_to | 2.16124256 |
22 | MP0002734_abnormal_mechanical_nocicepti | 2.14443121 |
23 | MP0001486_abnormal_startle_reflex | 2.13717078 |
24 | MP0000343_altered_response_to | 2.13295532 |
25 | MP0005451_abnormal_body_composition | 2.12885266 |
26 | MP0000604_amyloidosis | 2.12602781 |
27 | MP0002272_abnormal_nervous_system | 2.12352996 |
28 | MP0001501_abnormal_sleep_pattern | 2.10232161 |
29 | MP0009780_abnormal_chondrocyte_physiolo | 2.09803474 |
30 | MP0003705_abnormal_hypodermis_morpholog | 2.07469998 |
31 | MP0002148_abnormal_hypersensitivity_rea | 2.02605880 |
32 | MP0008260_abnormal_autophagy | 1.94484933 |
33 | MP0005423_abnormal_somatic_nervous | 1.93275305 |
34 | MP0003453_abnormal_keratinocyte_physiol | 1.93141082 |
35 | MP0001970_abnormal_pain_threshold | 1.87757749 |
36 | MP0002733_abnormal_thermal_nociception | 1.86379782 |
37 | MP0009278_abnormal_bone_marrow | 1.83979588 |
38 | MP0003633_abnormal_nervous_system | 1.79802808 |
39 | MP0001440_abnormal_grooming_behavior | 1.76709300 |
40 | MP0008569_lethality_at_weaning | 1.73410355 |
41 | MP0003183_abnormal_peptide_metabolism | 1.71211680 |
42 | MP0005257_abnormal_intraocular_pressure | 1.69978890 |
43 | MP0002735_abnormal_chemical_nociception | 1.65251860 |
44 | MP0002067_abnormal_sensory_capabilities | 1.58140726 |
45 | MP0000920_abnormal_myelination | 1.55924095 |
46 | MP0002090_abnormal_vision | 1.54921277 |
47 | MP0010386_abnormal_urinary_bladder | 1.52734934 |
48 | MP0010234_abnormal_vibrissa_follicle | 1.52238836 |
49 | MP0000858_altered_metastatic_potential | 1.50495222 |
50 | MP0003191_abnormal_cellular_cholesterol | 1.48891946 |
51 | MP0004811_abnormal_neuron_physiology | 1.48243805 |
52 | MP0001533_abnormal_skeleton_physiology | 1.47611550 |
53 | MP0002877_abnormal_melanocyte_morpholog | 1.46186005 |
54 | MP0005310_abnormal_salivary_gland | 1.45791002 |
55 | MP0003634_abnormal_glial_cell | 1.45219212 |
56 | MP0002557_abnormal_social/conspecific_i | 1.41612397 |
57 | MP0004510_myositis | 1.39914291 |
58 | MP0003631_nervous_system_phenotype | 1.37447949 |
59 | MP0001849_ear_inflammation | 1.37087844 |
60 | MP0005167_abnormal_blood-brain_barrier | 1.36096532 |
61 | MP0004885_abnormal_endolymph | 1.35975833 |
62 | MP0004947_skin_inflammation | 1.34229636 |
63 | MP0005025_abnormal_response_to | 1.33712035 |
64 | MP0001853_heart_inflammation | 1.33364374 |
65 | MP0005166_decreased_susceptibility_to | 1.33333109 |
66 | MP0003303_peritoneal_inflammation | 1.32033556 |
67 | MP0005365_abnormal_bile_salt | 1.30139921 |
68 | MP0008438_abnormal_cutaneous_collagen | 1.26430385 |
69 | MP0008004_abnormal_stomach_pH | 1.26066279 |
70 | MP0003448_altered_tumor_morphology | 1.25937434 |
71 | MP0003879_abnormal_hair_cell | 1.25920018 |
72 | MP0005386_behavior/neurological_phenoty | 1.25191617 |
73 | MP0004924_abnormal_behavior | 1.25191617 |
74 | MP0003300_gastrointestinal_ulcer | 1.24396358 |
75 | MP0000955_abnormal_spinal_cord | 1.24271831 |
76 | MP0003279_aneurysm | 1.20800028 |
77 | MP0002066_abnormal_motor_capabilities/c | 1.20580696 |
78 | MP0002184_abnormal_innervation | 1.19128604 |
79 | MP0005000_abnormal_immune_tolerance | 1.18551428 |
80 | MP0009840_abnormal_foam_cell | 1.16597189 |
81 | MP0003123_paternal_imprinting | 1.16110290 |
82 | MP0006082_CNS_inflammation | 1.15975403 |
83 | MP0004130_abnormal_muscle_cell | 1.15293726 |
84 | MP0000569_abnormal_digit_pigmentation | 1.13649851 |
85 | MP0002229_neurodegeneration | 1.13154061 |
86 | MP0009785_altered_susceptibility_to | 1.12490336 |
87 | MP0001545_abnormal_hematopoietic_system | 1.12289313 |
88 | MP0005397_hematopoietic_system_phenotyp | 1.12289313 |
89 | MP0009764_decreased_sensitivity_to | 1.11865908 |
90 | MP0002882_abnormal_neuron_morphology | 1.11379366 |
91 | MP0008874_decreased_physiological_sensi | 1.09316576 |
92 | MP0005076_abnormal_cell_differentiation | 1.07863180 |
93 | MP0005646_abnormal_pituitary_gland | 1.07078853 |
94 | MP0003091_abnormal_cell_migration | 1.05434856 |
95 | MP0005535_abnormal_body_temperature | 1.05199995 |
96 | MP0008469_abnormal_protein_level | 1.04911555 |
97 | MP0003566_abnormal_cell_adhesion | 1.03854395 |
98 | MP0002089_abnormal_postnatal_growth/wei | 1.03606808 |
99 | MP0001542_abnormal_bone_strength | 1.02808027 |
100 | MP0000685_abnormal_immune_system | 1.02208201 |
101 | MP0008961_abnormal_basal_metabolism | 0.99019992 |
102 | MP0001845_abnormal_inflammatory_respons | 0.97611280 |
103 | MP0000013_abnormal_adipose_tissue | 0.97181743 |
104 | MP0003632_abnormal_nervous_system | 0.96534249 |
105 | MP0000778_abnormal_nervous_system | 0.95949037 |
106 | MP0001502_abnormal_circadian_rhythm | 0.95430314 |
107 | MP0003806_abnormal_nucleotide_metabolis | 0.93144092 |
108 | MP0006054_spinal_hemorrhage | 0.91500641 |
109 | MP0000681_abnormal_thyroid_gland | 0.91011727 |
110 | MP0005023_abnormal_wound_healing | 0.89075136 |
111 | MP0004142_abnormal_muscle_tone | 0.88032768 |
112 | MP0002896_abnormal_bone_mineralization | 0.87383510 |
113 | MP0001790_abnormal_immune_system | 0.85958794 |
114 | MP0005387_immune_system_phenotype | 0.85958794 |
115 | MP0001905_abnormal_dopamine_level | 0.85810603 |
116 | MP0001984_abnormal_olfaction | 0.84448581 |
117 | MP0002452_abnormal_antigen_presenting | 0.84310346 |
118 | MP0005666_abnormal_adipose_tissue | 0.83188711 |
119 | MP0005595_abnormal_vascular_smooth | 0.82063989 |
120 | MP0002069_abnormal_eating/drinking_beha | 0.79917222 |
121 | MP0003045_fibrosis | 0.79202411 |
122 | MP0001765_abnormal_ion_homeostasis | 0.77959796 |
123 | MP0000751_myopathy | 0.77400904 |
124 | MP0010155_abnormal_intestine_physiology | 0.75677696 |
125 | MP0004019_abnormal_vitamin_homeostasis | 0.75665665 |
126 | MP0001177_atelectasis | 0.75084827 |
127 | MP0005390_skeleton_phenotype | 0.74016344 |
128 | MP0000747_muscle_weakness | 0.73414358 |
129 | MP0003795_abnormal_bone_structure | 0.73350005 |
130 | MP0002723_abnormal_immune_serum | 0.73196043 |
131 | MP0002152_abnormal_brain_morphology | 0.72840623 |
132 | MP0006276_abnormal_autonomic_nervous | 0.71705396 |
133 | MP0005375_adipose_tissue_phenotype | 0.71187123 |
134 | MP0004043_abnormal_pH_regulation | 0.69841679 |
135 | MP0008872_abnormal_physiological_respon | 0.69625124 |
136 | MP0001299_abnormal_eye_distance/ | 0.69195827 |
137 | MP0004145_abnormal_muscle_electrophysio | 0.68435823 |
138 | MP0001664_abnormal_digestion | 0.66681180 |
139 | MP0005645_abnormal_hypothalamus_physiol | 0.64998178 |
140 | MP0004233_abnormal_muscle_weight | 0.63914660 |
141 | MP0005671_abnormal_response_to | 0.63459139 |
142 | MP0002118_abnormal_lipid_homeostasis | 0.62635522 |
143 | MP0009333_abnormal_splenocyte_physiolog | 0.62405274 |
144 | MP0004185_abnormal_adipocyte_glucose | 0.61299657 |
145 | MP0004484_altered_response_of | 0.59937089 |
146 | MP0001835_abnormal_antigen_presentation | 0.59194823 |
147 | MP0004085_abnormal_heartbeat | 0.57481487 |
148 | MP0003724_increased_susceptibility_to | 0.56876684 |
149 | MP0003283_abnormal_digestive_organ | 0.56593500 |
150 | MP0004742_abnormal_vestibular_system | 0.56164585 |
151 | MP0002796_impaired_skin_barrier | 0.55972389 |
152 | MP0001819_abnormal_immune_cell | 0.55375341 |
153 | MP0001963_abnormal_hearing_physiology | 0.54993627 |
154 | MP0002420_abnormal_adaptive_immunity | 0.53983881 |
155 | MP0002998_abnormal_bone_remodeling | 0.49420248 |
156 | MP0005464_abnormal_platelet_physiology | 0.47700873 |
157 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.47678737 |
158 | MP0002254_reproductive_system_inflammat | 0.45407235 |
159 | MP0005165_increased_susceptibility_to | 0.45236196 |
160 | MP0000230_abnormal_systemic_arterial | 0.44228172 |
161 | MP0002419_abnormal_innate_immunity | 0.43442290 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 5.66446826 |
2 | Focal motor seizures (HP:0011153) | 5.16851069 |
3 | Supranuclear gaze palsy (HP:0000605) | 4.60589806 |
4 | Mutism (HP:0002300) | 4.21870309 |
5 | Focal seizures (HP:0007359) | 4.21438708 |
6 | Increased cerebral lipofuscin (HP:0011813) | 4.13336083 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.08272580 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.08272580 |
9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.08272580 |
10 | Nuclear cataract (HP:0100018) | 4.01362364 |
11 | Visual hallucinations (HP:0002367) | 3.97466378 |
12 | Action tremor (HP:0002345) | 3.94831058 |
13 | Neurofibrillary tangles (HP:0002185) | 3.93748942 |
14 | Dysostosis multiplex (HP:0000943) | 3.85098117 |
15 | Cerebral inclusion bodies (HP:0100314) | 3.52322445 |
16 | Systemic lupus erythematosus (HP:0002725) | 3.43389045 |
17 | Neuronal loss in central nervous system (HP:0002529) | 3.34542217 |
18 | Vertebral compression fractures (HP:0002953) | 3.27486054 |
19 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.26978617 |
20 | Atonic seizures (HP:0010819) | 3.23898071 |
21 | Postural instability (HP:0002172) | 3.19951251 |
22 | Ankle clonus (HP:0011448) | 3.12678734 |
23 | Papilledema (HP:0001085) | 3.08706526 |
24 | Abnormality of macrophages (HP:0004311) | 3.07546822 |
25 | Mucopolysacchariduria (HP:0008155) | 3.04316593 |
26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.04316593 |
27 | Depression (HP:0000716) | 3.00725365 |
28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.97724936 |
29 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.97724936 |
30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.97724936 |
31 | Generalized tonic-clonic seizures (HP:0002069) | 2.97380711 |
32 | Epileptic encephalopathy (HP:0200134) | 2.96510841 |
33 | Upper motor neuron abnormality (HP:0002127) | 2.94873260 |
34 | Absence seizures (HP:0002121) | 2.88753525 |
35 | Retinal atrophy (HP:0001105) | 2.81196144 |
36 | Dialeptic seizures (HP:0011146) | 2.76448506 |
37 | Arterial tortuosity (HP:0005116) | 2.75355678 |
38 | Hemiplegia (HP:0002301) | 2.74502984 |
39 | Abnormal eating behavior (HP:0100738) | 2.73263713 |
40 | Apathy (HP:0000741) | 2.71382298 |
41 | Progressive cerebellar ataxia (HP:0002073) | 2.67631847 |
42 | Prolonged neonatal jaundice (HP:0006579) | 2.63210651 |
43 | Progressive neurologic deterioration (HP:0002344) | 2.61568025 |
44 | Axonal loss (HP:0003447) | 2.60362900 |
45 | Febrile seizures (HP:0002373) | 2.55189877 |
46 | Diminished motivation (HP:0000745) | 2.54896419 |
47 | Truncal ataxia (HP:0002078) | 2.54719886 |
48 | Glomerulonephritis (HP:0000099) | 2.53680290 |
49 | Vacuolated lymphocytes (HP:0001922) | 2.52523781 |
50 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.52418840 |
51 | Urinary urgency (HP:0000012) | 2.47069371 |
52 | Purpura (HP:0000979) | 2.46858604 |
53 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.46680472 |
54 | * Dysmetria (HP:0001310) | 2.43937809 |
55 | Loss of speech (HP:0002371) | 2.43456391 |
56 | Dysdiadochokinesis (HP:0002075) | 2.40494371 |
57 | Diplopia (HP:0000651) | 2.39237502 |
58 | Abnormality of binocular vision (HP:0011514) | 2.39237502 |
59 | Status epilepticus (HP:0002133) | 2.38634501 |
60 | Vascular tortuosity (HP:0004948) | 2.38333286 |
61 | Personality changes (HP:0000751) | 2.36540509 |
62 | Rapidly progressive (HP:0003678) | 2.36395992 |
63 | Insidious onset (HP:0003587) | 2.34689096 |
64 | Termporal pattern (HP:0011008) | 2.34689096 |
65 | Anxiety (HP:0000739) | 2.34383909 |
66 | Amyloidosis (HP:0011034) | 2.33450963 |
67 | Torticollis (HP:0000473) | 2.32709666 |
68 | Pathologic fracture (HP:0002756) | 2.32182313 |
69 | Abnormal social behavior (HP:0012433) | 2.30942603 |
70 | Impaired social interactions (HP:0000735) | 2.30942603 |
71 | Poor eye contact (HP:0000817) | 2.29796268 |
72 | Disinhibition (HP:0000734) | 2.29046927 |
73 | Cerebral aneurysm (HP:0004944) | 2.28213425 |
74 | * Intention tremor (HP:0002080) | 2.28078219 |
75 | Dementia (HP:0000726) | 2.28056557 |
76 | Myocardial infarction (HP:0001658) | 2.27611731 |
77 | Abnormality of complement system (HP:0005339) | 2.25338647 |
78 | Abnormality of the periventricular white matter (HP:0002518) | 2.24593585 |
79 | Global brain atrophy (HP:0002283) | 2.24399051 |
80 | Megalencephaly (HP:0001355) | 2.23690786 |
81 | Inappropriate behavior (HP:0000719) | 2.22461739 |
82 | Hyperparathyroidism (HP:0000843) | 2.21819078 |
83 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.20080695 |
84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19184891 |
85 | Stereotypic behavior (HP:0000733) | 2.17760518 |
86 | Spastic gait (HP:0002064) | 2.17626992 |
87 | Hyperacusis (HP:0010780) | 2.16123856 |
88 | Complement deficiency (HP:0004431) | 2.15580968 |
89 | Bradykinesia (HP:0002067) | 2.15454383 |
90 | Rigidity (HP:0002063) | 2.15396984 |
91 | Bone pain (HP:0002653) | 2.10988271 |
92 | Lower limb asymmetry (HP:0100559) | 2.09736852 |
93 | Asymmetric septal hypertrophy (HP:0001670) | 2.09523519 |
94 | Ventricular fibrillation (HP:0001663) | 2.09505425 |
95 | Agnosia (HP:0010524) | 2.08823151 |
96 | Thoracic kyphosis (HP:0002942) | 2.07502254 |
97 | Progressive inability to walk (HP:0002505) | 2.05764300 |
98 | Recurrent abscess formation (HP:0002722) | 2.05558902 |
99 | Annular pancreas (HP:0001734) | 2.05139856 |
100 | Focal dystonia (HP:0004373) | 2.05085199 |
101 | Distal upper limb amyotrophy (HP:0007149) | 2.04708252 |
102 | Upper limb amyotrophy (HP:0009129) | 2.04708252 |
103 | Clumsiness (HP:0002312) | 2.04398528 |
104 | Cardiomegaly (HP:0001640) | 2.03132874 |
105 | Abnormality of the lower motor neuron (HP:0002366) | 2.01572122 |
106 | Gaze-evoked nystagmus (HP:0000640) | 2.00960027 |
107 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97469735 |
108 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97469735 |
109 | Aplasia involving bones of the extremities (HP:0009825) | 1.97469735 |
110 | Eczematoid dermatitis (HP:0000976) | 1.96627192 |
111 | J-shaped sella turcica (HP:0002680) | 1.95970900 |
112 | Increased CSF protein (HP:0002922) | 1.95783601 |
113 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95474504 |
114 | Lower limb muscle weakness (HP:0007340) | 1.94859978 |
115 | Hemiparesis (HP:0001269) | 1.94535831 |
116 | Hepatosplenomegaly (HP:0001433) | 1.94220371 |
117 | Urinary incontinence (HP:0000020) | 1.93639266 |
118 | Increased serum ferritin (HP:0003281) | 1.93301373 |
119 | Hand muscle atrophy (HP:0009130) | 1.92828609 |
120 | Peripheral demyelination (HP:0011096) | 1.91964066 |
121 | Impaired smooth pursuit (HP:0007772) | 1.91710969 |
122 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91417149 |
123 | Striae distensae (HP:0001065) | 1.90915786 |
124 | Premature rupture of membranes (HP:0001788) | 1.90857527 |
125 | Xanthomatosis (HP:0000991) | 1.89599883 |
126 | Pheochromocytoma (HP:0002666) | 1.89522383 |
127 | Agitation (HP:0000713) | 1.89409076 |
128 | Craniofacial dystonia (HP:0012179) | 1.87806284 |
129 | Amblyopia (HP:0000646) | 1.85576344 |
130 | Psychosis (HP:0000709) | 1.83792276 |
131 | Abnormality of the thoracic spine (HP:0100711) | 1.80317703 |
132 | Recurrent bacterial skin infections (HP:0005406) | 1.74862564 |
133 | Insomnia (HP:0100785) | 1.74146772 |
134 | Joint stiffness (HP:0001387) | 1.73477173 |
135 | Thin bony cortex (HP:0002753) | 1.72704154 |
136 | Zonular cataract (HP:0010920) | 1.69421137 |
137 | Deep venous thrombosis (HP:0002625) | 1.68822523 |
138 | Cervical subluxation (HP:0003308) | 1.68148898 |
139 | Mediastinal lymphadenopathy (HP:0100721) | 1.66749916 |
140 | Multiple enchondromatosis (HP:0005701) | 1.66740623 |
141 | Autoimmune thrombocytopenia (HP:0001973) | 1.66461623 |
142 | Distal lower limb muscle weakness (HP:0009053) | 1.66173530 |
143 | Metaphyseal irregularity (HP:0003025) | 1.65062616 |
144 | Distal lower limb amyotrophy (HP:0008944) | 1.63100976 |
145 | Protrusio acetabuli (HP:0003179) | 1.60792104 |
146 | Polygenic inheritance (HP:0010982) | 1.59712113 |
147 | Malnutrition (HP:0004395) | 1.57104847 |
148 | Tetraparesis (HP:0002273) | 1.57024087 |
149 | Interstitial pulmonary disease (HP:0006530) | 1.56031059 |
150 | Multiple lipomas (HP:0001012) | 1.55293352 |
151 | Ovoid vertebral bodies (HP:0003300) | 1.55095173 |
152 | Abnormality of the lumbar spine (HP:0100712) | 1.54691326 |
153 | Paraparesis (HP:0002385) | 1.52442215 |
154 | Hemorrhage of the eye (HP:0011885) | 1.52165841 |
155 | Short nail (HP:0001799) | 1.48604846 |
156 | Abnormality of the motor neurons (HP:0002450) | 1.47695920 |
157 | Abnormal neuron morphology (HP:0012757) | 1.47695920 |
158 | Hypophosphatemia (HP:0002148) | 1.47363962 |
159 | Nephritis (HP:0000123) | 1.46528670 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K9 | 4.08242881 |
2 | IRAK3 | 4.04588128 |
3 | NME2 | 4.02386070 |
4 | EPHA4 | 3.82601527 |
5 | NTRK3 | 3.49056565 |
6 | TESK1 | 3.08760179 |
7 | KSR2 | 3.00031484 |
8 | RIPK4 | 2.97520159 |
9 | MAP3K11 | 2.70811456 |
10 | TAOK2 | 2.46620051 |
11 | CAMKK1 | 2.43640306 |
12 | DAPK2 | 2.37388620 |
13 | MINK1 | 2.31867348 |
14 | PRKD3 | 2.28366316 |
15 | TESK2 | 2.15633440 |
16 | PAK6 | 2.14523939 |
17 | NTRK1 | 2.11695909 |
18 | PIM2 | 2.09111385 |
19 | ARAF | 2.04831166 |
20 | MAP3K4 | 1.99563656 |
21 | MAP3K13 | 1.91017946 |
22 | ICK | 1.88564844 |
23 | MAP3K2 | 1.85882759 |
24 | CAMKK2 | 1.83443755 |
25 | SIK1 | 1.82984397 |
26 | LMTK2 | 1.76216014 |
27 | LIMK1 | 1.75078621 |
28 | ABL2 | 1.65764522 |
29 | TBK1 | 1.60778991 |
30 | FES | 1.50845483 |
31 | MAP2K4 | 1.42172384 |
32 | MAP3K3 | 1.40835253 |
33 | CDK5 | 1.40319766 |
34 | NTRK2 | 1.39509126 |
35 | TRIB3 | 1.39168523 |
36 | SCYL2 | 1.34884112 |
37 | GRK5 | 1.34736389 |
38 | TGFBR2 | 1.29727096 |
39 | CDC42BPA | 1.27667307 |
40 | MARK1 | 1.27377401 |
41 | KSR1 | 1.26646373 |
42 | STK38 | 1.25519431 |
43 | PAK4 | 1.24920329 |
44 | LATS2 | 1.21506908 |
45 | EPHA2 | 1.20587235 |
46 | MAP2K7 | 1.18373637 |
47 | CAMK1G | 1.17583192 |
48 | MATK | 1.17463549 |
49 | MAP3K12 | 1.17264995 |
50 | DAPK1 | 1.16830291 |
51 | RIPK1 | 1.16401345 |
52 | SMG1 | 1.15215276 |
53 | TYRO3 | 1.10887687 |
54 | RET | 1.07720602 |
55 | PDPK1 | 1.07272959 |
56 | PDK1 | 1.07180182 |
57 | STK39 | 1.01648675 |
58 | OXSR1 | 1.00859922 |
59 | MAP3K14 | 1.00191758 |
60 | PRKCH | 0.99950660 |
61 | TAOK1 | 0.99401605 |
62 | CDK19 | 0.95811175 |
63 | BLK | 0.92460302 |
64 | ERN1 | 0.90697227 |
65 | CAMK1D | 0.89983152 |
66 | MAP2K3 | 0.89430486 |
67 | RAF1 | 0.88713160 |
68 | SIK2 | 0.88030619 |
69 | FGR | 0.87732814 |
70 | PHKG1 | 0.85525384 |
71 | PHKG2 | 0.85525384 |
72 | MAP3K1 | 0.82977457 |
73 | PRKCG | 0.82797477 |
74 | PLK2 | 0.81965861 |
75 | IRAK2 | 0.80722333 |
76 | CAMK1 | 0.80568752 |
77 | PTK2B | 0.80166515 |
78 | TNK2 | 0.77689307 |
79 | EPHB2 | 0.76234335 |
80 | BRAF | 0.75465921 |
81 | TYK2 | 0.74246210 |
82 | PRPF4B | 0.73907148 |
83 | PTK2 | 0.73866120 |
84 | PRKG2 | 0.73851323 |
85 | MAPKAPK5 | 0.72583275 |
86 | MARK2 | 0.72050999 |
87 | MOS | 0.71990104 |
88 | SGK223 | 0.71134064 |
89 | SGK494 | 0.71134064 |
90 | UHMK1 | 0.70183589 |
91 | STK11 | 0.69856259 |
92 | DMPK | 0.69434520 |
93 | TTN | 0.67966682 |
94 | CDK15 | 0.67647530 |
95 | WNK1 | 0.67587200 |
96 | CAMK2A | 0.67353845 |
97 | GRK7 | 0.66883933 |
98 | CDK18 | 0.66848924 |
99 | PINK1 | 0.66564622 |
100 | CSF1R | 0.65906567 |
101 | CDK14 | 0.64824714 |
102 | SGK3 | 0.64365758 |
103 | FYN | 0.60697408 |
104 | PRKD2 | 0.58721956 |
105 | CAMK2B | 0.58232038 |
106 | JAK1 | 0.55646308 |
107 | FGFR4 | 0.55378102 |
108 | CDK11A | 0.54545275 |
109 | RPS6KL1 | 0.54072107 |
110 | RPS6KC1 | 0.54072107 |
111 | MAPK12 | 0.53896389 |
112 | MAP2K1 | 0.53749945 |
113 | MST1R | 0.53609386 |
114 | PDK2 | 0.53302768 |
115 | JAK2 | 0.52123662 |
116 | BCKDK | 0.51758823 |
117 | IKBKB | 0.49745021 |
118 | DAPK3 | 0.49388302 |
119 | MAPK13 | 0.48983714 |
120 | CAMK2G | 0.48773619 |
121 | ALK | 0.48696775 |
122 | PKN2 | 0.46152912 |
123 | PAK3 | 0.45427799 |
124 | PRKCZ | 0.44459450 |
125 | RPS6KA2 | 0.44112554 |
126 | CSK | 0.43009912 |
127 | SGK1 | 0.42859019 |
128 | IRAK4 | 0.42272859 |
129 | MAP2K6 | 0.42094644 |
130 | BMX | 0.40757970 |
131 | MAPK4 | 0.38370394 |
132 | FRK | 0.38238631 |
133 | PDGFRA | 0.38003715 |
134 | CDK6 | 0.37749488 |
135 | CAMK4 | 0.37695024 |
136 | FER | 0.37498024 |
137 | DDR2 | 0.36586352 |
138 | MAPKAPK3 | 0.36585954 |
139 | SGK2 | 0.36426202 |
140 | HCK | 0.36225186 |
141 | CAMK2D | 0.36193208 |
142 | BMPR2 | 0.36148051 |
143 | MAP3K7 | 0.35535860 |
144 | DYRK1B | 0.35252513 |
145 | MTOR | 0.34719150 |
146 | SIK3 | 0.33431062 |
147 | PAK1 | 0.33117926 |
148 | PBK | 0.31792021 |
149 | ROCK2 | 0.31748471 |
150 | RPS6KA6 | 0.31738267 |
151 | SRC | 0.31392011 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.90460072 |
2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.35467087 |
3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25079355 |
4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.24237334 |
5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.18360517 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.09361751 |
7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.06377921 |
8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.97694921 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.96943620 |
10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.91047376 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 1.89923235 |
12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.88772547 |
13 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.82528341 |
14 | Morphine addiction_Homo sapiens_hsa05032 | 1.81606812 |
15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.76946359 |
16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.75021709 |
17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73040184 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.71492860 |
19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70344840 |
20 | Lysosome_Homo sapiens_hsa04142 | 1.65510165 |
21 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.59538245 |
22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.54545306 |
23 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52777354 |
24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.52295815 |
25 | Insulin secretion_Homo sapiens_hsa04911 | 1.51087581 |
26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.47806204 |
27 | Renin secretion_Homo sapiens_hsa04924 | 1.46076299 |
28 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44411733 |
29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44243487 |
30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.37554801 |
31 | Bladder cancer_Homo sapiens_hsa05219 | 1.36285480 |
32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.35101192 |
33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34097684 |
34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33563747 |
35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.33498365 |
36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29702391 |
37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29277404 |
38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.27430113 |
39 | Long-term depression_Homo sapiens_hsa04730 | 1.26654143 |
40 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.25084469 |
41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.21650593 |
42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.21348760 |
43 | Other glycan degradation_Homo sapiens_hsa00511 | 1.20150029 |
44 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17725757 |
45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17195353 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.15228052 |
47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.14936701 |
48 | Prion diseases_Homo sapiens_hsa05020 | 1.14741805 |
49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14125320 |
50 | Glioma_Homo sapiens_hsa05214 | 1.12768508 |
51 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11699074 |
52 | Gap junction_Homo sapiens_hsa04540 | 1.07849211 |
53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07045846 |
54 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.06707026 |
55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06015664 |
56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05654177 |
57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.02101679 |
58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97892488 |
59 | Amoebiasis_Homo sapiens_hsa05146 | 0.97008677 |
60 | Shigellosis_Homo sapiens_hsa05131 | 0.95860223 |
61 | Taste transduction_Homo sapiens_hsa04742 | 0.95481666 |
62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94509540 |
63 | Malaria_Homo sapiens_hsa05144 | 0.94486800 |
64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93933324 |
65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90715037 |
66 | Endocytosis_Homo sapiens_hsa04144 | 0.89987970 |
67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88834207 |
68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88685833 |
69 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85056771 |
70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85047983 |
71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84779909 |
72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83443728 |
73 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83106479 |
74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82052764 |
75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81913843 |
76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81023621 |
77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79593767 |
78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79381150 |
79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78308183 |
80 | Legionellosis_Homo sapiens_hsa05134 | 0.76877658 |
81 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76573536 |
82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76562695 |
83 | Hepatitis C_Homo sapiens_hsa05160 | 0.75325423 |
84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73631922 |
85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71578003 |
86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71082135 |
87 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.70442112 |
88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70204218 |
89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70157875 |
90 | Tuberculosis_Homo sapiens_hsa05152 | 0.66389960 |
91 | Phagosome_Homo sapiens_hsa04145 | 0.65440264 |
92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65334760 |
93 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65244407 |
94 | Melanogenesis_Homo sapiens_hsa04916 | 0.63164984 |
95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62793844 |
96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62515599 |
97 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62385807 |
98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62280812 |
99 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61559937 |
100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59654501 |
101 | Apoptosis_Homo sapiens_hsa04210 | 0.59250304 |
102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.59244949 |
103 | Bile secretion_Homo sapiens_hsa04976 | 0.59234412 |
104 | Asthma_Homo sapiens_hsa05310 | 0.58583767 |
105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57637051 |
106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.56802813 |
107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56685954 |
108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56642503 |
109 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56558972 |
110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55837568 |
111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55796560 |
112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55532736 |
113 | Axon guidance_Homo sapiens_hsa04360 | 0.55417457 |
114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54882880 |
115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54782629 |
116 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54596443 |
117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53868847 |
118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53575339 |
119 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52596617 |
120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51865118 |
121 | Salmonella infection_Homo sapiens_hsa05132 | 0.51652229 |
122 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.51069505 |
123 | Allograft rejection_Homo sapiens_hsa05330 | 0.51068841 |
124 | Influenza A_Homo sapiens_hsa05164 | 0.50841170 |
125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50279581 |
126 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49993862 |
127 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48969336 |
128 | Pertussis_Homo sapiens_hsa05133 | 0.47908709 |
129 | Mineral absorption_Homo sapiens_hsa04978 | 0.47341500 |
130 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46593005 |
131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45145803 |
132 | Platelet activation_Homo sapiens_hsa04611 | 0.44976246 |
133 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44492576 |
134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43641334 |
135 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43452782 |
136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43011018 |
137 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42904948 |
138 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41540592 |
139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40588518 |
140 | Hepatitis B_Homo sapiens_hsa05161 | 0.40507251 |
141 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40119742 |
142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40094580 |
143 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40032146 |
144 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38462453 |
145 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38186248 |
146 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38039506 |
147 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37798541 |
148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37416899 |
149 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37412410 |
150 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37364847 |
151 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.36654016 |
152 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.35847405 |
153 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34093741 |
154 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33241755 |
155 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31066573 |
156 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.30458407 |